BNP Paribas Financial Markets’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

BNP Paribas Financial Markets’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-125,000	Closed	-$1.25M	–	4964
2022 Q3	$1.25M	Buy	+125,000	New	+$1.24M	﹤0.01%	2311

BNP Paribas Financial Markets's FLAC Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 125,000 shares — an estimated $1.25M sold.

BNP Paribas Financial Markets first reported a position in FLAC in Q3 2022 and held it in 1 quarter. The position peaked at $1.25M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

BNP Paribas Financial Markets reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
BNP Paribas Financial Markets sold 125,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.25M.
BNP Paribas Financial Markets first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q3 2022 and held it in 1 quarter.
BNP Paribas Financial Markets's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.25M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.